Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with cancer and referred for high-throughput genetic sequencing (a detailed type of DNA testing)
- People for whom a specialist multidisciplinary tumor board (a group of cancer specialists who review cases together) has approved the use of genome, exome, and RNA sequencing since January 1, 2021
- People who have agreed to allow their medical and genetic data to be used for research purposes and have not withdrawn that agreement
Who may not be able to join:
- People who have objected to or withdrawn their agreement for their data to be reused for research
- People whose case has not been reviewed and approved by the required specialist multidisciplinary tumor board prior to sequencing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Calculation of result turnaround time.; Treatment recommendation issued following the downstream multidisciplinary meeting
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.